Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005739 · ClinicalTrials.gov registry record
Behavioral Interventions for Control of TB
A clinical trial of Lung Diseases and Tuberculosis, sponsored by Columbia University.
- Completed
- Registry status
- 145
- Enrollment target
- 1
- Study location
NCT00005739: Completed study of Lung Diseases and Tuberculosis, sponsored by Columbia University.
NCT00005739 is a study of Lung Diseases and Tuberculosis that has completed, run by Columbia University. The registered enrollment target is 145 participants, below the 735-participant average among 31 other Lung Diseases trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005739, a study of Lung Diseases and Tuberculosis, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare alternative methods to ensure completion of treatment and preventive therapy for tuberculosis (TB) in inner cities, and to identify the most cost-effective methods to accomplish that. The basis for comparison included adherence rates and cost savings as primary outcomes, and other parameters such as patient satisfaction, development of social networks, and participation in support programs as secondary outcomes. Two clinical trials were conducted with patients from Harlem. Among those with active disease, a clinic-based surrogate family model was compared to traditional community-based directly observed therapy (DOT). Among those eligible for preventive therapy, a community-based intervention conducted by trained graduates of a TB DOT program (peer workers) was compared to traditional self-administered preventive treatment.
Primary Outcome
Prevalence of suspected and confirmed tuberculosis patients that continued treatment
Conditions Studied
Interventions
- BEHAVIORAL Community-based directly observed therapy (DOT)
- BEHAVIORAL Clinic directly observed therapy (DOT)
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 1995-09 |
| Est. Completion | 2015-12 |
What the finished NCT00005739 record still lists
NCT00005739 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 735-participant average among 31 other Lung Diseases trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Lung Diseases appearing as the primary indexed condition, and to 2 interventions - of which Community-based directly observed therapy (DOT) is the first listed.
NCT00005739 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00005739 about?
NCT00005739 is a clinical study titled "Behavioral Interventions for Control of TB". To compare alternative methods to ensure completion of treatment and preventive therapy for tuberculosis (TB) in inner cities, and to identify the most cost-effective methods to accomplish that. The basis for comparison included adherence rates and cost savings as primary outcomes, and other paramet...
What is the current status of trial NCT00005739?
This trial is currently completed. The enrollment target is 145 participants. The study started on 1995-09. Estimated completion is 2015-12.
What conditions does trial NCT00005739 study?
This clinical trial studies the following conditions: Lung Diseases, Tuberculosis.
What interventions are being tested in trial NCT00005739?
The interventions under investigation include: Community-based directly observed therapy (DOT) (BEHAVIORAL), Clinic directly observed therapy (DOT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00005739?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005739 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00005739's enrollment target sits among peer trials
145 19th of 31 higher than 13 of 31 other Lung Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
American Lung Association (ALA) Lung Health Cohort
RECRUITING
-
Data Collection Using Eko Digital Devices in a Clinical Setting
RECRUITING
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING · Phase 2
-
Deep Functional Phenotyping of the ALA Lung Health Cohort
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia